Partner Magazine logo 50

logo 50 | the Camlog Partner Magazine logo 50 | the Camlog Partner Magazine 28 | Products Products | 29 2 months New bone 27.13 % 22.97 % 21.03 % 44.57 % 31.16 % 14.86 % 28.30 % 40.87 % 64.11 % MinerOss® A Soft tissue 4 months 6 months Go to mandatory information MinerOss A is manufactured from human donor bone and is an allogeneic alternative to autologous grafts. MinerOss A is predominantly derived from human femoral heads from living donors following hip surgery. The cortical plate and unicortical block are harvested from the diaphysis of tissue donors post-mortem and processed. The human donor bone is processed by Cells+Tissuebank Austria (C+TBA), which is responsible for processing and providing the human tissue for medical restoration, according to a stringent serological screening protocol in a multi-step purification process for safe use. MinerOss A enables reliable and predictable results for the regeneration of bone defects. Scientific studies show that allografts are most similar to the patient's autologous bone in use and integrate quickly (Fig.1). [1–5] They therefore represent an excellent alternative to bone harvesting from the patient. In Fig. 1: Clinical evaluation - controlled regeneration of vital bone High biological regenerative capacity - MinerOss® A, the human bone substitute material PRODUCTS [1] Schmitt et al. Histological results after maxillary sinus augmentation with Straumann® BoneCeramic, Bio-Oss®, Puros®, and autologous bone. A randomized controlled clinical trial; Clin Oral Implants Res. 2013, 24, 576. [2] Solakoglu et al. Histological and immunohistochemical comparison of two different allogeneic bone grafting materials for alveolar ridge reconstruction: A prospective randomized trial in humans; Clin Implant Dent Relat Res. 2019, 21, 1002-1016. [3] Kloss et al. Customized allogeneic bone grafts for maxillary horizontal augmentation: A 5-year follow-up radiographic and histologic evaluation; Clin Case Rep. 2020, 8, 5. [4] Wen et al. Time analysis of alveolar ridge preservation using a combination of mineralized bone-plug and dense-polytetrafluoroethylene membrane: A histomorphometric study. J Periodontol. 2020 Feb;91(2):215-222. doi: 10.1002/JPER.19-0142. Epub 2019 Aug 19 [5] Kloss et al. Comparison of allogeneic and autogenous bone grafts for augmentation of alveolar ridge defects—A 12-month retrospective radiographic evaluation; Clin Oral Implants Res. 2018, 29, 1163. References MinerOss A is ideally suited for the following indications » Regeneration of periodontal osseous defects, even after cyst or root tip resections » Regeneration of extraction sockets and gaps between the alveolar wall and dental implants » Sinus floor augmentation » Horizontal augmentation of alveolar ridges » Three dimensional (horizontal and/or vertical) augmentation of the alveolar ridge MinerOss A is available as cancellous and cortico-cancellous granules, blocks as well as cortical plates. It is used in guided bone reconstruction (GBR) techniques in the jaw. » Proprietary tissue processing maintains tissue integrity » Bone from human donors (living donors: femoral heads, post-mortem donors: long bones/diaphysis) » Natural bone composition – mineralized human collagen » High biological regeneration capability and natural remodeling [4] » Osteoconductive properties support controlled tissue remodeling » 5 years shelf-life at room temperature (5–30 °C) Product features at a glance » In October 2022, BioHorizons Camlog launched an allogeneic bone substitute material on the German market under the brand name MinerOss A. The cancellous and cortico-cancellous granules as well as the blocks and plates of botiss biomaterials GmbH have been used successfully in clinical applications for many years. With the expansion of the biomaterial portfolio, Camlog offers a comprehensive range of products for virtually all requirements needed for the regeneration of hard and soft tissue deficits. addition, the dimensions of the extraction socket can be optimally preserved by applying MinerOss A. Due to its natural composition, the allogeneic biomaterial exhibits a high biological regenerative capacity with a natural remodeling behavior and supports controlled tissue remodeling through its osteoconductive properties. [4] For vertical or horizontal alveolar ridge defects, the use of a membrane is recommended to protect the graft. To preserve soft tissue volume or thicken tissues, combining MinerOss A with an acellular dermal tissue matrix, such as NovoMatrix®, is a predictable treatment option.

RkJQdWJsaXNoZXIy MTE0MzMw